Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
RTX Corp
RTX
$283B
| $40.4M | 0.08% |
721,063
-499,361
| -41% | -$30.7M |
|
302
Unum
UNM
$13.9B
| $40.3M | 0.08% |
1,257,222
-557,333
| -31% | -$19.2M |
|
303
Labcorp
LH
$27.3B
| $40.1M | 0.08% |
430,489
+60,052
| +16% | +$6.21M |
|
|
WNR
304
DELISTED
Western Refining Inc
WNR
| $40.1M | 0.08% |
908,928
+360,461
| +66% | +$16.2M |
|
305
Equifax
EFX
$22.6B
| $40M | 0.08% |
411,395
+130,078
| +46% | +$12.9M |
|
|
ZNGA
306
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $39.9M | 0.08% |
17,514,699
+4,754,203
| +37% | +$12.2M |
|
|
ESRX
307
DELISTED
Express Scripts Holding Company
ESRX
| $39.8M | 0.08% |
491,509
-81,108
| -14% | -$7.06M |
|
|
ALR
308
DELISTED
Alere Inc
ALR
| $39.8M | 0.08% |
826,425
+360,404
| +77% | +$18.7M |
|
309
Regency Centers
REG
$13.9B
| $39.7M | 0.08% |
638,643
-67,527
| -10% | -$4.16M |
|
310
CenterPoint Energy
CNP
$25.5B
| $39.6M | 0.08% |
+2,196,616
| New | +$41.1M |
|
|
RAX
311
DELISTED
Rackspace Hosting Inc
RAX
| $39.6M | 0.08% |
1,605,530
+1,038,688
| +183% | +$33.5M |
|
312
Flotek Industries
FTK
$894M
| $39.5M | 0.08% |
394,351
+61,341
| +18% | +$6.22M |
|
313
IQVIA
IQV
$42.8B
| $39.5M | 0.08% |
567,423
+326,886
| +136% | +$24.5M |
|
|
SIVB
314
DELISTED
SVB Financial Group
SIVB
| $39.2M | 0.08% |
339,652
+274,492
| +421% | +$36.8M |
|
315
Ciena
CIEN
$56B
| $39.2M | 0.08% |
1,891,750
+1,005,755
| +114% | +$23.4M |
|
316
CME Group
CME
$98.9B
| $39.1M | 0.08% |
421,401
+221,595
| +111% | +$21.1M |
|
317
Williams Companies
WMB
$86.2B
| $39M | 0.08% |
1,059,664
-1,823,737
| -63% | -$90.8M |
|
|
ATW
318
DELISTED
Atwood Oceanics
ATW
| $39M | 0.08% |
2,632,880
+2,052,940
| +354% | +$40M |
|
|
CST
319
DELISTED
CST Brands, Inc.
CST
| $38.9M | 0.08% |
1,156,259
+1,060,554
| +1,108% | +$38.4M |
|
|
MIC
320
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $38.8M | 0.08% |
520,028
-391,177
| -43% | -$31.2M |
|
321
Eastman Chemical
EMN
$8.47B
| $38.8M | 0.08% |
599,665
-289,603
| -33% | -$21.4M |
|
|
UCB
322
United Community Banks
UCB
$4.29B
| $38.8M | 0.08% |
1,897,863
-127,897
| -6% | -$2.61M |
|
323
CALL
BP
BP
$115B
| $38.7M | 0.07% |
1,503,686
+672,214
| +81% | +$19.7M |
|
|
DATA
324
DELISTED
Tableau Software, Inc.
DATA
| $38.6M | 0.07% |
+483,474
| New | +$50.1M |
|
325
Patterson-UTI
PTEN
$4.71B
| $38.4M | 0.07% |
2,926,088
-2,848,196
| -49% | -$45.1M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.